RGNX vs SNY
Regenxbio Inc (RGNX) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
SNY (SNY) common stock.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
SNY does not have a complete income-statement cache yet.
RGNX currently screens at market cap $440.4M. SNY currently screens at market cap $0.
Not investment advice. Open the RGNX and SNY stock pages for the full models.
Not investment advice.